RLYB
RLYB
NASDAQ · Biotechnology

Rallybio Corp

$16.16
-0.03 (-0.19%)
As of Aug 15, 2:10 AM ET ·
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Buy 0 0%
Hold 3 50%
Sell 3 50%
Price Target
Analyst Price Target -14.4% upside
Low Target $9.36
Average Target $13.83
High Target $17.78
Current Price $16.16
Current
$16.16
Target
$13.83
$9.36 $13.83 avg $17.78
Scenario Analysis
Bear Case
$9.36
-42.1%
Low target
Base Case
$13.83
-14.4%
Avg target
Bull Case
$17.78
+10.0%
High target
Risk/Reward
0.2x
Unfavorable
Price in Context
52-Week High
$17.57
-8.0% from high
52-Week Low
$3.67
+340.3% from low
Target vs 52W High
$13.83
-21.3% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 +3.3%
AMGN
Amgen Inc
Hold 43 49% $190.87 -54.0%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +162.1%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 37 81% $438.34 -13.3%
REGN
Regeneron Pharmaceuticals
Buy 37 70% $76.80 -90.4%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -53.9%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -44.0%
BIIB
Biogen Inc
Buy 43 67% $91.45 -56.4%